FabiFlu

Glenmark Pharmaceuticals Limited FabiFlu approved for COVID-19 treatment in India; priced at Rs 103 a tablet

Glenmark Pharmaceuticals Limited developed active pharmaceutical ingredient and formulation for FabiFlu through in-house R&D; DCGI allowed fasttrack trials with Phase ...